Latest News-Haotian Strategic Investment Consultants (Shenzhen) Co., LTD Mediaroom_Page

CPIC Life (HK) Launches the "CPIC Elite Club" to Build Core Competitiveness of "CPIC Services"

HONG KONG, Jan. 3, 2023 /PRNewswire/ -- It marked the first anniversary of China Pacific Life Insur...

2023-01-03 17:03 2641

CPIC: "CPIC Elite Club" Creates High Quality Services Escorts for Healthy Living

HONG KONG, Dec. 21, 2022 /PRNewswire/ -- The insurance industry is a "stabiliser" for social develo...

2022-12-21 15:26 3648

CPIC Life (HK) Launches "CPIC Elite Club" Offering Variety of Benefits to Customers

HONG KONG, Dec. 19, 2022 /PRNewswire/ -- China Pacific Life Insurance (H.K.) Company Limited ("CPIC...

2022-12-19 20:00 1766

Treadwell Therapeutics Announces A Presentation at the 2022 ASH Annual Meeting Featuring a Clinical Trial Update on CFI-400945, an oral PLK4 inhibitor

NEW YORK, Dec. 13, 2022 /PRNewswire/ -- Treadwell Therapeutics, a clinical-stage biotechnology comp...

2022-12-13 22:30 3467

Treadwell Therapeutics Announces A Presentation at the 2022 SABCS Annual Meeting Featuring a Clinical Trial Update on CFI-402257, a Best-in-Class TTK inhibitor

NEW YORK, Dec. 9, 2022 /PRNewswire/ -- Treadwell Therapeutics, a clinical-stage biotechnology compa...

2022-12-09 22:30 6341

Treadwell Therapeutics Announces Presentations at the 2022 San Antonio Breast Cancer Symposium Featuring a Clinical Trial Update on the CFI-402257 and CFI-400945 programs

NEW YORK, Nov. 21, 2022 /PRNewswire/ -- Treadwell Therapeutics, a clinical-stage biotechnology comp...

2022-11-21 22:00 3492

Treadwell Therapeutics Announces A Presentation at the 2022 SITC Annual Meeting Featuring a Clinical Trial Update on CFI-402411, a First-in-Class HPK1 inhibitor

NEW YORK, Nov. 11, 2022 /PRNewswire/ -- Treadwell Therapeutics, a clinical-stage biotechnology comp...

2022-11-11 22:09 15596

CPIC Achieved a Revenue of RMB255.1 Billion In 20221H, Improving its Margin and Adhering To the Long-Term Value

HONG KONG, Aug. 31, 2022 /PRNewswire/ -- On 28 August, the insurance giant China Pacific Insurance ...

2022-08-31 15:26 3481

CPIC's Insurance Business Revenue Growth in 1H 2022 hit a New High in The Past Three Years

Operating Profit Attributable to the Parent Company Increased by 9.9% YOY HONG KONG, Aug. 29, 2022 ...

2022-08-29 08:42 2391

CMGE ANNOUNCES 2022 INTERIM RESULTS

Revenue recorded RMB1.233 billion, with overseas revenue up 3.6% and R&D investment up nearly 70% ...

2022-08-26 16:17 3578

CPIC: Hand in hand to create prosperous business, rooting in Hong Kong to gallop forward courageously

HONG KONG, July 6, 2022 /PRNewswire/ -- 1 July 2022 marked the 25th anniversary ofHong Kong's retur...

2022-07-06 15:35 3074

CPIC celebrates 25th anniversary of Hong Kong's return to China, prospering together with GBA

HONG KONG, July 5, 2022 /PRNewswire/ -- Hong Kong marked the significant 25th anniversary of its re...

2022-07-05 14:03 2737

Arrail Group Announces FY2022 Annual Results

Steady Development of Various Businesses and Outstanding Achievements in Dual Brand Strategy HONG ...

2022-06-28 15:10 3773

HUANENG POWER INTERNATIONAL, INC. Announcement of Intention to Delist American Depositary Shares from the New York Stock Exchange

And Intention to Deregister and Terminate Reporting Obligations under the U.S. Securities Exchange ...

2022-06-17 18:24 3188

Treadwell Announces Initiation of Patient Dosing in TWT-203, a Phase 1b/2 study of TTK Inhibitor, CFI-402257, in Patients with ER+/Her2- Breast cancer

NEW YORK and HONG KONG, June 14, 2022 /PRNewswire/ -- Treadwell Therapeutics, a clinical-stage biot...

2022-06-14 04:01 2275

Centre on Customer Needs CPIC's 31st Anniversary Board of Directors Leads Quality Development

HONG KONG, May 13, 2022 /PRNewswire/ -- As a social "stabilizer" and an economic "booster", insur...

2022-05-13 15:31 3130

Treadwell Therapeutics Announces Fast Track Designation Granted by the FDA to CFI-400945 for the Treatment of Acute Myeloid Leukemia

NEW YORK and HONG KONG, April 27, 2022 /PRNewswire/ -- Treadwell Therapeutics, a clinical-stage bio...

2022-04-27 04:30 1869

HUANENG POWER INTERNATIONAL, INC. RMB956 MILLION NET LOSS ATTRIBUTABLE TO EQUITY HOLDERS FOR THE FIRST QUARTER OF 2022 DECREASED BY 129.96%

BEIJING, April 26, 2022 /PRNewswire/ -- Huaneng Power International, Inc. ("the Company") (NYSE: HN...

2022-04-27 00:02 2161

Treadwell Therapeutics Announces the Appointment of J.D. Mowery, as Chief Operating Officer

NEW YORK and HONG KONG, April 20, 2022 /PRNewswire/ -- Treadwell Therapeutics (" Treadwell"), a clin...

2022-04-20 04:30 1765

HUANENG POWER INTERNATIONAL, INC. DOMESTIC ON-GRID ELECTRICITY IN THE FIRST QUARTER OF 2022 INCREASED BY 2. 42% YEAR-ON-YEAR

BEIJING, April 14, 2022 /PRNewswire/ -- Huaneng Power International, Inc. ("HPI", the "Company") (N...

2022-04-14 23:40 1765